QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER
QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER Basic information
- Product Name:
- QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER
- Synonyms:
-
- Pentamethoxyquercetin
- QUERCETINPENTAMETHYLETHER
- PENTAMETHYLQUERCETIN
- 2-(3,4-Dimethoxyphenyl)-3,5,7-trimethoxy-4H-1-benzopyran-4-one
- 3,3',4',5,7-Pentamethoxyflavone
- Quercetin 3,3',4',5,7-pentamethyl ether
- 3,5,7,3',4'-PENTAMETHOXYFLAVONE
- QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER
- CAS:
- 1247-97-8
- MF:
- C20H20O7
- MW:
- 372.37
- Mol File:
- 1247-97-8.mol
QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER Chemical Properties
- Melting point:
- 152-156°C
- Boiling point:
- 561.9±50.0 °C(Predicted)
- Density
- 1.29±0.1 g/cm3(Predicted)
- form
- Solid
- color
- White to light brown
- LogP
- 2.370 (est)
QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER Usage And Synthesis
Uses
3,5,7,3’,4’-Pentamethoxyflavone is a Ca2+ channel inhibitor. 3,5,7,3’,4’-Pentamethoxyflavone can protect DNA from oxidative damage. 3,5,7,3’,4’-Pentamethoxyflavone can induce relaxation of the human corpus cavernosum through calcium mobilization-related mechanisms. 3,5,7,3’,4’-Pentamethoxyflavone can promote the expression of eNOS and cystathionine gamma lyase CSE proteins in middle-aged male rats and regulate vascular function. 3,5,7,3’,4’-Pentamethoxyflavone can be used in research related to diabetes and cardiovascular diseases[1][2][4].
in vivo
3,5,7,3’,4’-Pentamethoxyflavone (22 mg/kg; twice daily; 6 weeks; p.o.) can promote the expression of eNOS and CSE proteins in middle-aged male rats, and regulate vascular function by antagonizing the contraction of phenylephrine and enhancing the vasodilation of acetylcholine[4].
| Animal Model: | Middle-aged (12–14 month old) Wistar male rats[4]. |
| Dosage: | 22 mg/kg |
| Administration: | Oral gavage (p.o.); twice daily; 6 weeks |
| Result: | Caused a decrease in plasma glucose and an increase in plasma HDL cholesterol levels of the rats. |
References
[1] Jakhar R, et al. 3,5,7,3',4'-pentamethoxyflavone, a quercetin derivative protects DNA from oxidative challenges: potential mechanism of action. J Photochem Photobiol B. 2014 Feb 5;131:96-103. DOI:10.1016/j.jphotobiol.2014.01.003
[2] Jansakul C, et al. Relaxant mechanisms of 3, 5, 7, 3', 4'-pentamethoxyflavone on isolated human cavernosum. Eur J Pharmacol. 2012 Sep 15;691(1-3):235-44. DOI:10.1016/j.ejphar.2012.07.019
[3] Mayangsari Y, et al. 3,5,7,3',4'-Pentamethoxyflavone Enhances the Barrier Function through Transcriptional Regulation of the Tight Junction in Human Intestinal Caco-2 Cells. J Agric Food Chem. 2021 Sep 8;69(35):10174-10183. DOI:10.1021/acs.jafc.1c04295
[4] Yorsin S, et al. Increased vascular eNOS and cystathionine-γ-lyase protein after 6 weeks oral administration of 3, 5, 7, 3', 4'-pentamethoxyflavone to middle-aged male rats. Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1183-1194. DOI:10.1007/s00210-016-1280-0
QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHERSupplier
- Tel
- 4006356688 18621169109
- market03@meryer.com
- Tel
- +86-028-82633397 18982077548
- cwb1@biopurify.cn
- Tel
- 021-51320588
- tauto@tautobiotech.com
- Tel
- 027-87465837 19945049750
- sales@finetechnology-ind.com
- Tel
- 18607101326 15172504745
- aileen@chemfaces.com
QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER(1247-97-8)Related Product Information
- 3',4',5,7-TETRAMETHOXYFLAVONE
- Naringenin 7-O-β-D-Glucuronide (Mixture of Diastereomers)
- PONCIRIN
- 4',5-DIHYDROXY-7-METHOXYFLAVONE
- Naringenin
- GARDENIN B
- MOSLOFLAVONE
- MEDICAGOL
- Quercetin-7-O-β-D-glucopyranoside
- QUERCETIN-3,5,7,3',4'-PENTAMETHYL ETHER
- 3,3',4',5,6,7,8-heptamethoxyflavone
- QUERCETINPENTAACETATE
- HEPTAMETHOXYFLAVONE
- 3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tetrakis(2-hydroxyethyl) ether
- RARECHEM BW GA 0418
- RARECHEM BW GA 0417
- RARECHEM BW GA 0416
- penta-O-ethylquercetin